Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, Piper Sandler Analyst Says
Amgen (NASDAQ:AMGN – Get Free Report) had its target price increased by Piper Sandler from $310.00 to $329.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical research company’s stock. Piper Sandler’s price target suggests a potential upside of 10.90% from the company’s previous […]
Amgen (NASDAQ:AMGN – Get Free Report) had its target price increased by Piper Sandler from $310.00 to $329.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical research company’s stock. Piper Sandler’s price target suggests a potential upside of 10.90% from the company’s previous […]
